NVAX is fundamentally weak with a shallow pipeline and no products currenly marketed to fund earnings and so research. On the 15 minute chart , NVAX is seen near to its demand zone as shown by the Luxalgo indicator. In the meanwhile, the RSI indicator shows considerable recent strength which is decreased today. So the question is whether NVAX can dead...
MRNA has been in a bearish trend from quite a while but now it has started to move back up Its following a very good resistance trend retest . The recent drop was due to bad news but it should be back on track soon According to FIB after crossing 176 the bullish reversal will be confirmed Entry @ 176 SL 170 TP after 202+
MRNA is not looking too good. What we can see is a weekly bearish engulfing candle after clear rejection from the upsloping resistance line. Rejection was nasty therefore we're seeing instant follow through. You can short it now with a final target at the support which is the entry for longs too. At the support, flip bullish and take a long position. The target...
$MRNA has bottomed recently, and has been trending logically in the daily timeframe, we have a 2nd signal forming here, continuing the uptrend that kicked off on March 13th. Upside can be substantial given broad market action, so I suggest to get involved with the stock (and likely also $PFE soon) here. Best of luck! Cheers, Ivan Labrie.
$PFE has a similar setup to $MRNA here, both are attractive buys from a valuation and technical standpoint here and have been beaten down lately due to the situation with rates, banking woes and negative news about COVID vaccines, COVID lock downs, etc. (a general more negative perception of health measures taken by the US govt since 2020 likely part of the reason...
NVAX as seen on the weekly chart has been in price distress for a long time. It has only one product on the market due to various issues with the FDA process. It has a variety of products in development as linked below. The question is whether it will run out of cash before a sustained revenue stream develops. FDA approvals for the pipeline products could take...
Initial Notes - Personally did not trade today, Analysis was on point, rest of week should be exciting SPY - So it looks like scenario 3 that I mentioned on my list last night played out today. We saw both targets to the upside and downside get hit. Premarket we were about 15 cents off of the upside target before opening and pushing higher than yesterdays high....
SPY - Interesting day on SPY. We said yesterday that the markets could realistically go either way, but we were watching more so to the downside due to the failed 2U formed on Monday that was followed by a 2D yesterday, and having that small bearish bias by simply playing what is in front of us vs using other reasons for bias. SPY ended up gapping up premarket and...
SPY - I had no real bias going into today's session other than mentioning last night that downside was more likely to come today because of the failed 2U daily created on monday. We closed slightly red after seeing a decent drop to the high 393 area, forming a weak bearish 2D. Going into wednesday (3/29), I am hoping to see some downward continuation to the...
There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
SPY - Once again we were bullish going into today and ended up getting that upside movement we wanted. Tomorrow is FOMC so no real prediction for tomorrows movement other than some chop leading up to the news. As far as the news goes, I am leaning more on the bullish side but quite honestly that is purely a guess. Trading light tomorrow if I take anything, and not...
$MRNA started playing this since it was in the low $20s and then got rid of it at the start of this year. And IMO this is headed under $100. It will get a kick start when the next Pandemic happens and WHO rules lockdowns across the world. Regardless of the hype, I don't see any reason to take a position in this ticker. The only outcome is, EXIT for me :) Although...
Moderna shows 145 or 115 as a target on the short side.. Building a very good base up here or it's preparing to break below 115 to target 80$. Nonetheless been short since 210/share.
$MRNA - Moderna breaking down. 50MA sloping down. Wave 3 of 5 Down Waves. See notations in chart. Just a technical thesis. Not investment advice...
Move back down towards 115 incoming once again? Was very solid support on all previous visits
Pfizer may provide a great risk to reward setup. Multi factor trade setup on pfizer likely sees a technical bounce. Keep in mind markets are weak.
There is a daily wolfe wave setup that triggered on December 15. Today at the open, MRNA opened inside day and traded +4% within 30 mins of the trading day. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line; however, the linear lines do not converge. The projected target is approx 167 which is...
Moderna - 30d expiry - We look to Sell at 186.88 (stop at 198.38) Price action continued to range between key support & resistance (120 - 190) and we expect this to continue. Daily signals are mildly bearish. Posted a Double Top formation. An Evening Doji Star formation has been posted at the high. We look for a temporary move higher. Offers ample...